Articles tagged with Virus Testing
Researchers developed novel liquid-coated air filters that capture viable bacterial and viral samples for analysis. The filters show promise in improving early pathogen detection and aerosol sampling efforts.
Research suggests that long COVID patients share similar lingering negative effects on physical, mental, and social well-being with individuals who have other illnesses. The study found moderate-to-severe residual symptoms in 40% of COVID-positive participants and 54% of those who tested negative.
A systematic review of national clinical practice guidelines in Europe found that fewer than half include HIV testing recommendations for patients with medical conditions indicating HIV infection. This omission hinders efforts to stop the spread of HIV through timely diagnosis, affecting the lives of people living with HIV.
A large study from Argentina found that COVID-19 vaccines remain effective in preventing death in children and adolescents, regardless of the predominant circulating variant. The study's results show that vaccinated children had a 67% reduced risk of death related to COVID-19 infection during the omicron period.
A Brazilian team developed an electrochemical immunosensor to detect SARS-CoV-2 antibodies, achieving 88.7% sensitivity and 100% specificity in just five minutes. The device can be adapted for other diseases and has potential for monitoring seroconversion and seroprevalence.
A study of over 1,000 healthcare workers found that medical masks may be as effective as N95 respirators in preventing COVID-19 infection. However, the results varied across countries and were influenced by factors such as vaccine use and variant circulating during the pandemic.
A new microfluidic multiplexed chip uses CRISPR technology to detect SARS-CoV-2 and monitor antibiotic levels, offering a rapid and sensitive solution for managing COVID-19 patients. The test omits nucleic acid amplification and can be easily adapted to new virus mutations.
A mass testing pilot in Liverpool found a 25% reduction in COVID-19 related hospital admissions, preventing 6,829 infections and 239 hospital admissions. The study suggests large-scale voluntary community testing can reduce virus transmission and prevent hospital admissions.
A recent study found that the Omicron sub-lineage BQ.1.1 is resistant to all approved antibody therapies, posing a risk to high-risk patients. The researchers emphasize the importance of developing new antibody therapies specifically targeted at currently circulating and future viral variants.
A new study published in PLOS Medicine found that COVID-19 vaccination provides significant protection against reinfection, with varying levels of effectiveness (60-94%) across different variants. The study analyzed data from over 200,000 people in Denmark and showed that vaccination offered up to 71% protection during the Alpha period...
A handheld diagnostic lab developed by UCLA researchers can fully automate pooled testing and detect multiple diseases, reducing costs and usage of scarce supplies. The technology can be easily manufactured, deployed, and performed at a doctor's office or mass testing sites, helping authorities prepare for future pandemics.
A new AI technology has been developed to automatically diagnose lung diseases such as tuberculosis and pneumonia, freeing up radiographers and reducing waiting times for test results. The system, which uses X-ray imaging and deep learning algorithms, achieved a 98% accuracy rate during extensive testing.
A study by researchers at the University of Washington found that infants are less likely to contract COVID-19 and develop severe symptoms if their mothers test positive for the virus. The study suggests that infant infection is mostly related to household transmission, not solely from maternal risk.
A UK study found substantial monkeypox transmission before symptoms appear, with 53% of cases occurring pre-symptomatically. The study's findings have important implications for infection control globally and may affect isolation and contact tracing policies.
A Rutgers study found community-based groups more effective than health-care organizations in raising awareness of at-home testing availability and increasing its completion rates. The research suggests that partnerships between CBOs and HCOs are crucial to strengthen health outcomes.
A study found that 60% of healthcare workers tested positive for COVID with antigen tests after five days and 50% were positive after seven days. Antigen tests are a better proxy for indicating infectiousness than PCR tests.
A novel genetic analysis by University of Ottawa researchers reveals that climate change could lead to an increased risk of viral spillover in the High Arctic. This increased risk may result in new viruses infecting previously uninfected hosts, potentially leading to emerging pandemics.
A study on long COVID found increased rates of healthcare use two months after SARS-CoV-2 infection, particularly among women. The largest increase was seen in a small subset of patients, who required an extra week or more in hospital compared to uninfected individuals.
A recent poll reveals that 48% of people aged 50-80 have purchased at least one home health test, including COVID-19 and DNA tests. Notably, 82% of older adults express interest in future medical tests at home, while 90% agree to share results with their healthcare provider.
A new testing method for tuberculosis may make diagnosis easier by using saliva instead of sputum, which can be unpleasant and impractical. The method has shown high sensitivity in detecting the bacteria that causes TB, but its effectiveness in people with HIV is less clear.
A novel COVID-19 vaccine developed by Brazilian scientists combines two SARS-CoV-2 proteins to trigger a cellular immune response. The vaccine, called SpiN, showed promise in animal trials, protecting against three strains of the virus and reducing viral load by up to 50 times.
A method combining local health department data and hospital records identifies new COVID-19 outbreak waves, helping inform public health strategies. Researchers detected two large waves in Harris County, with the second taking longer to spread, highlighting the importance of continuous monitoring and community collaboration.
A Johns Hopkins Medicine study found that COVID-19 booster shots are essential for maintaining long-term immunity against infection, particularly among older adults. The results support the CDC vaccination guidelines recommending COVID-19 boosters and highlight the importance of continued research on factors affecting immunity.
Mathematical models suggest that only 1 in 5 COVID-19 cases were counted worldwide, resulting in an estimated 600 million to 2.4 billion actual cases globally. The wide range of estimated cases highlights the problems with accuracy of reported numbers due to data tampering, inconsistent reporting, and lack of uniformity.
Researchers developed DNA nets to detect and impede COVID-19, offering a fast, sensitive, and low-cost testing platform. The technique also showed potential as an antiviral treatment, inhibiting the virus's spread in live cell cultures.
Researchers developed a faster, more affordable method to analyze serological data and predict COVID-19 wave behavior. The study showed that vaccination boosted immunity, with hybrid immunity producing higher protection levels. Antibody levels rose quickly after the first dose, especially in cities where case numbers were highest.
Researchers developed an engineered Cas13 system that detects SARS-CoV-2 in biological samples with high sensitivity and speed. The new platform outperforms traditional PCR testing, finding 10 out of 11 positives and no false positives in clinical samples.
A new Scottish study found no direct association between COVID-19 infection and increased type 1 diabetes risk in adults and children under 35, suggesting testing explanations for the observed link. Increased testing around the time of diagnosis may be partly responsible for the observed increase.
A new wearable device study, DETECT, found that sensor data significantly improves seven-day average predictions for COVID-19 infection by 32.9% in California and 12.2% nationwide. The study tracked physiological changes before symptom onset, providing a valuable tool for predicting viral threats.
A nationwide study of 1.2 million children in Norway suggests a possible association between COVID-19 and new-onset type 1 diabetes. The study found that children who contracted COVID-19 were more likely to develop type 1 diabetes, but the absolute risk remains low.
Researchers have discovered a COVID-like virus in Russian bats that can infect human cells and is resistant to current vaccines. The new virus, named Khosta-2, poses a threat to global health and highlights the need for developing universal vaccines to protect against sarbecoviruses.
A team of scientists from SMART and NTU Singapore has developed a quick test kit that can determine a person's immunity against COVID-19 and its variants based on antibodies detected in a blood sample. The test kit, which requires just 10 minutes to show results, can be easily adapted for new variants of concern and other diseases.
A team of scientists from SMART and NTU Singapore has developed a rapid point-of-care test kit that measures antibodies against SARS-COV-2 and its variants, offering personalized vaccination strategies. The test kit requires just 10 minutes to show results and has up to 93% accuracy.
A team of UCF researchers has developed a nanomaterial-based disinfectant that can kill several serious viruses, including SARS and Zika. The disinfectant uses white light activation to regenerate its antiviral properties, making it effective in minimizing surface-to-surface spread of viruses.
A new genomic test can predict a patient's risk of developing severe COVID-19, according to research from the University of Virginia Health System. The test, called CovGENE, analyzes genes expressed in a person's blood to determine if they may experience a severe disease course with increased risk of death.
The University of Arkansas has been awarded $699,604 by NIST to enhance a Wi-Fi nano-biosensor for palm-sized SARS-COV-II detection. The new sensor will confirm whether the coronavirus is alive or dead, significantly improving detection accuracy.
Researchers developed a novel method to evaluate how mutations in the N protein impact rapid antigen tests' ability to detect antibodies. The study found that most major past and present variants of concern do not contain mutations affecting test performance, but some sequences could impact detection.
Three widely used rapid antigen tests showed declined performance when only nasal self-sampling was used, but improved with combined throat and nasal sampling. Only one test met WHO standards, emphasizing the need for manufacturers to consider extended testing protocols.
The Society for Healthcare Epidemiology of America highlights the need to strengthen antibiotic stewardship programs to address overuse of antibiotics in early stages of viral epidemics. The guidance provides strategies for hospitals and healthcare personnel to improve antibiotic prescribing and diagnostic testing.
A recent study finds that fungal infections during the pandemic are a significant public health problem with limited treatment options. The interaction between pathogen and host may be different in people with compromised immunity, leading to increased mortality rates among severe COVID-19 patients.
A new study published in Frontiers in Medicine found that around 30% of people with long COVID experience a decreased sense of smell, with 29.9% reporting persistent anosmia after 12 weeks. Researchers also discovered an elevated prevalence of blurred vision and hearing-related symptoms after three months.
Coronavirus levels in wastewater accurately predicted hospitalization peaks and healthcare pressure, enabling timely forecasting. The study's results demonstrate the value of virus surveillance in monitoring ongoing outbreaks.
Two large clinical trials found that vitamin D supplements did not reduce the risk of covid-19 or acute respiratory infections, contradicting previous studies' mixed results. The trials involved over 30,000 adults and showed no effect of vitamin D supplementation on infection rates or side effects.
A new study found that young Swiss military personnel with confirmed Covid-19 infections experienced symptoms like fatigue, reduced sense of smell, and psychological problems for up to 180 days. Long-term effects included increased BMI, high cholesterol, and lower physical stamina, suggesting a higher risk of metabolic disorders and ca...
Researchers developed a mobile phone app using AI to accurately detect COVID-19 infection in people's voices, outperforming lateral flow tests. The app achieved an accuracy of 89% and can be used for remote testing, enabling rapid screening of populations.
A digital platform was used in six communities to report COVID-19 self-test results to health departments, resulting in increased reporting rates among household beneficiaries. The study suggests that this approach could be an effective way to improve public health surveillance and tracking of COVID-19 cases.
A new study found that school-aged children can successfully use a nasal swab to obtain their own COVID-19 test specimen, providing data for recommendations on self-swabbing in schools and other settings. The study showed that children as young as 4 years old can follow instructions and collect their own samples with high accuracy.
A study by Hokkaido University scientists found a close association between clinical cases of COVID-19 and viral loads in wastewater, with the viral loads picking up to two days before the cases were detected. The researchers used wastewater-based epidemiology to track the spread of SARS-CoV-2 in the Tokyo 2020 Olympics and Paralympics.
Researchers developed a new quantitative RT-qPCR assay to detect and quantify the Omicron variant of SARS-CoV-2 in wastewater. The assay revealed that Omicron displaced Delta as the dominant variant within just 3 weeks in an Italian population.
A study of 57 people with mild COVID-19 found that the average duration of infectiousness was five days, and two-thirds of cases remained infectious for at least five days after symptoms began. Lateral flow tests can safely shorten self-isolation by identifying when someone is no longer contagious.
Researchers at Terasaki Institute create micro-organospheres for direct viral infection, immune cell penetration, and high-throughput therapeutic drug screening. The technology holds promise for personalized medicine, tumor therapy and rapid drug testing.
A Rutgers scientist has developed a highly sensitive DNA test that can detect Lyme disease in horses, a condition that can cause long-term complications. The test, called genomic hybrid capture assay, was tested on a sick horse and successfully identified the pathogen, allowing for early diagnosis and treatment.
A study found a strong link between post-COVID loss of smell or taste and memory problems in patients. Those with the most severe sensory disorders performed worse in cognitive tests, especially memorization.
A team of researchers from Princeton University and the Broad Institute created a fast, accurate, and equipment-free diagnostic test for COVID-19. The test uses CRISPR technology to detect SARS-CoV-2 variants and can be performed at home without special equipment, improving sensitivity and specificity compared to existing tests.
A new test developed by MIT researchers measures neutralizing antibodies in a blood sample to predict COVID-19 immunity. The easy-to-use test could help people decide on necessary protections and may be particularly useful for those with weakened immune systems.
A new poll shows that 61% of people over 50 who have already gotten at least one dose of COVID-19 vaccine are very likely to roll up their sleeves for an updated booster shot. Health providers' recommendations will play a crucial role in increasing vaccination rates among older adults.
A new point-of-care diagnostic device combines CRISPR with electrochemical sensing to track COVID-19 infections' course via saliva. The device can simultaneously detect both SARS-CoV-2 RNA and antibodies, offering a cost-effective alternative to traditional lab tests.
Researchers at Karolinska Institutet developed a refined clinical COVID-19 test to classify Omicron BA.1/BA.2 variants. The test showed increased viral RNA levels in BA.2 cases, helping explain its aggressive spread and dominance.
Penn State researchers developed an at-home saliva-based testing platform that detects COVID-19 with the same sensitivity as PCR tests. The platform uses RT-LAMP technology to provide rapid results in 45 minutes.
Researchers at Imperial College London developed a new rapid test called CrisprZyme, which detects biomarkers in the body to diagnose non-infectious diseases like heart attacks and cancers. The test works at room temperature with colorimetric analysis, eliminating the need for amplification and temperature control.